Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvio Garattini

Showing results (31-40 of 165) with videos related to

Pageof 17
Sort By:
European Journal of Internal Medicine|May 25, 2010
Alternative medical practices: flashbacks from the Dark AgesSilvio Garattini, Vittorio Bertele'
European Journal of Internal Medicine|December 6, 2016
Animal testing is still the best way to find new treatments for patientsSilvio Garattini, Giuliano Grignaschi
BMJ (Clinical Research Ed.)|December 13, 2003
Drug sales in four European countries still differSilvio Garattini, Livio Garattini
Lancet (London, England)|June 17, 2008
Rare diseases: what's next?Giuseppe Remuzzi, Silvio Garattini
The British Journal of Psychiatry : the Journal of Mental Science|February 3, 2007
Regulatory policies on medicines for psychiatric disorders: is Europe on target?Corrado Barbui, Silvio Garattini
Recenti Progressi in Medicina|January 27, 2007
[False innovations in clinical research]Silvio Garattini, Vittorio Bertele'
Lancet (London, England)|October 26, 2007
Non-inferiority trials are unethical because they disregard patients' interestsSilvio Garattini, Vittorio Bertele'
European Journal of Clinical Pharmacology|January 23, 2016
Trials, Regulation and tribulationsCarlo Petrini, Silvio Garattini
European Journal of Clinical Pharmacology|June 22, 2022
Scientific and ethical issues in add-on designs for antidiabetic drugsLidia Staszewsky, Silvio Garattini
European Journal of Clinical Pharmacology|November 29, 2017
Benefits, benefits, once more benefits... with no risk? Stop overlooking the harms of medicinesSilvio Garattini, Vittorio Bertele'
Pageof 17

Showing results (31-40 of 165) with videos related to

Sort By:
Pageof 17
European Journal of Internal Medicine|May 25, 2010
Alternative medical practices: flashbacks from the Dark AgesSilvio Garattini, Vittorio Bertele'
European Journal of Internal Medicine|December 6, 2016
Animal testing is still the best way to find new treatments for patientsSilvio Garattini, Giuliano Grignaschi
BMJ (Clinical Research Ed.)|December 13, 2003
Drug sales in four European countries still differSilvio Garattini, Livio Garattini
Lancet (London, England)|June 17, 2008
Rare diseases: what's next?Giuseppe Remuzzi, Silvio Garattini
The British Journal of Psychiatry : the Journal of Mental Science|February 3, 2007
Regulatory policies on medicines for psychiatric disorders: is Europe on target?Corrado Barbui, Silvio Garattini
Recenti Progressi in Medicina|January 27, 2007
[False innovations in clinical research]Silvio Garattini, Vittorio Bertele'
Lancet (London, England)|October 26, 2007
Non-inferiority trials are unethical because they disregard patients' interestsSilvio Garattini, Vittorio Bertele'
European Journal of Clinical Pharmacology|January 23, 2016
Trials, Regulation and tribulationsCarlo Petrini, Silvio Garattini
European Journal of Clinical Pharmacology|June 22, 2022
Scientific and ethical issues in add-on designs for antidiabetic drugsLidia Staszewsky, Silvio Garattini
European Journal of Clinical Pharmacology|November 29, 2017
Benefits, benefits, once more benefits... with no risk? Stop overlooking the harms of medicinesSilvio Garattini, Vittorio Bertele'
Pageof 17